Figure 4From: Long-term outcome of early stage prostate cancer treated with brachytherapy analysis after a mean follow-up of 7 years Patients whose PPC < 50% had less biochemical recurrence likelihood than those whose PPC ≥ 50% (P = 0.006). Back to article page